• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

SCYX:US

6.8500 USD 0.1300 1.86%

As of 20:10:00 ET on 08/01/2014.

Snapshot for SCYNEXIS Inc (SCYX)

Open: 6.1100 Day's Range: 6.1100 - 6.9500 Volume: 3,278
Previous Close: 6.9800 52wk Range: 6.0900 - 10.0000 1-Yr Rtn: -

Stock Chart for SCYX

No chart data available.
  • SCYX:US 6.8500
  • 1D
  • 1M
  • 1Y
6.9800
Interactive SCYX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SCYX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -2.0450
Est. PEG Ratio -
Market Cap (M USD) 58.24
Shares Outstanding (M) 8.50
30 Day Average Volume 15,683
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SCYX

No data available

Company Profile & Key Executives for SCYX

SCYNEXIS, Inc. provides pharmaceutical products. The Company discovers, develops, and distributes intravenous drug for the treatment of serious and life-threatening invasive fungal infections in humans. SCYNEXIS serves customers in the United States.

Yves J RibeillPresident/CEOCharles F Osborne Jr "Chuck"Chief Financial Officer
Eileen C PruetteGeneral Counsel
More Company Profile & Key Executives for SCYX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil